Ocular Therapeutix (OCUL) Receivables - Net (2016 - 2025)
Ocular Therapeutix (OCUL) has 13 years of Receivables - Net data on record, last reported at $30.6 million in Q4 2025.
- For Q4 2025, Receivables - Net fell 5.37% year-over-year to $30.6 million; the TTM value through Dec 2025 reached $30.6 million, down 5.37%, while the annual FY2025 figure was $30.6 million, 5.37% down from the prior year.
- Receivables - Net reached $30.6 million in Q4 2025 per OCUL's latest filing, roughly flat from $30.8 million in the prior quarter.
- Across five years, Receivables - Net topped out at $32.4 million in Q4 2024 and bottomed at $13.6 million in Q1 2021.
- Average Receivables - Net over 5 years is $24.6 million, with a median of $24.4 million recorded in 2023.
- Peak YoY movement for Receivables - Net: surged 551.84% in 2021, then decreased 8.98% in 2023.
- A 5-year view of Receivables - Net shows it stood at $21.1 million in 2021, then grew by 0.9% to $21.3 million in 2022, then grew by 22.76% to $26.2 million in 2023, then grew by 23.72% to $32.4 million in 2024, then fell by 5.37% to $30.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $30.6 million in Q4 2025, $30.8 million in Q3 2025, and $30.4 million in Q2 2025.